With emerging improvement in screening and treatment, most patients with prostate cancer (PCa) live for a long period beyond their diagnosis. Erectile dysfunction (ED) and bowel and urinary incontinence have been shown to be the most bothersome side-effects of most PCa treatment options for patients. With increasing long-term survival, most PCa patients face the prospect of experiencing symptoms, side-effects of available treatment options, and diminished quality of life. The objective of the study was to explore the impact of treatment-induced ED on masculinity among Black South African PCa patients. Twenty (20) prostate cancer patients, selected through purposive sampling and receiving some form of treatment at Pietersburg tertiary Hospital, with ages ranging from 67 to 85 years (mean age = 76 years; SD = 5.3), participated in the study. In-depth, individual semi-structured interviews were used to collect data and analyzed through Interpretative Phenomenological Analysis (IPA). The findings indicate that ED threatens or adversely impacts the participants’ perceptions of their sense of masculinity leading to diminished quality of life. The results demonstrate that loss of masculinity brought about by PCa treatment-induced ED is experienced both physically as well as psychologically. The results highlight a need for collaboration between medical and psychological professionals in the management of PCa patients. This is crucial for improving the overall health related quality of life for patients.

Psychosocial factors such as diabetes distress, depression, anxiety, social support, stigma, coping styles, and quality of life play a critical role in shaping mental health outcomes among males living with type 2 diabetes. Despite their importance, systematic evidence on how these factors influence mental health remains limited. Objective: This protocol aims to synthesize existing evidence on psychosocial factors associated with mental health outcomes among males living with type 2 diabetes. Eligibility Criteria: Studies will be included if they focus on males aged 18 years and above diagnosed with type 2 diabetes and examine psychosocial factors in relation to mental health outcomes. Qualitative, quantitative, and mixed-methods designs will be considered. Exclusion criteria include studies focused on females, males under 18, or those with type 1 diabetes; studies exclusively evaluating interventions (e.g., CBT trials, self-management programs); non-English publications; and studies published before 2015. Confounders such as co-morbidities and lifestyle factors will be included if reported alongside psychosocial exposures, but studies focusing solely on these without mental health outcomes will be excluded. Information Sources: The search strategy will be guided by the PICO framework, and such searches will be conducted in Scopus, MEDLINE (PubMed), CINAHL, and Web of Science using Medical Subject Headings (MeSH) for articles published in English between January 2016 and December 2026. Risk of Bias: Two independent reviewers will screen studies, with disagreements resolved by a third reviewer. Risk of bias will be assessed using the JBI Critical Appraisal Checklist. Data Synthesis: Eligible studies will undergo narrative thematic synthesis. Confidence in findings will be evaluated using the JBI ConQual approach. Ethics and Dissemination: Ethical approval is not required. This protocol is registered with PROSPERO (CRD420261299482). Results will be disseminated through peer-reviewed journals and conferences. Conclusion: This protocol outlines a transparent plan to review psychosocial factors influencing mental health in men with type 2 diabetes, guiding gender-sensitive strategies that integrate mental health into diabetes care.

With improvement in screening and treatment, most men with prostate cancer (PCa) live longer following diagnosis. Erectile dysfunction (ED), bowel and urinary incontinent have been shown to be the most bothersome side-effects of most PCa treatment for patients. With increasing long-term survival, most PCa face the prospect of experiencing symptoms, side-effects of treatment, and diminished health related quality of life. The objective of the study was to explore the impact of treatment induced ED on hegemonic masculinity among black South African PCa survivors. Twenty (20) prostate cancer survivors, selected through purposive sampling, with ages ranging from 67 to 85 years (meanage = 76yrs; SD = 5.3) participated in the study. In-depth, individual semi-structured interviews was used to collect data and analyzed through Interpretative Phenomenological Analysis (IPA). The findings indicate that ED threatens or adversely impact the participants’ perceptions of their sense of masculinity leading to diminished quality of life. The results demonstrates that loss of masculinity brought about by PCa treatment induced ED is experienced both physically as well as psychologically. The results highlight a need for collaboration between medical and psychological professionals in the management of PCa patients. This is crucial to improve the overall health related quality of life for patients.